Clinical Trial Update: Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.

View source ↗

Summary

An exploratory study evaluating the feasibility of predicting decline in chronic inflammatory demyelinating polyneuropathy patients during adaptation of intrave…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Liege | Conditions: Chronic Inflammatory Demyelinating Polyneuropathy | Status: RECRUITING